Cadila Pharmaceuticals (Europe) Ltd is a significant subsidiary of Cadila Pharmaceuticals Limited, a globally recognized Indian pharmaceutical enterprise. Established in 2000-11-23, the company operates as an active, long-term entity focused on the European market. Located at Amba House, Harrow, HA1 1BA, it maintains a strong international presence, strategically positioned to serve European clients. As a Ltd company, Cadila Pharmaceuticals (Europe) Ltd specializes in the development, manufacture, and distribution of a diverse portfolio of pharmaceutical products. The company’s core business centers around providing high-quality medicines and treatments across various therapeutic areas, including cardiovascular, oncology, and pain management. The company’s services encompass the entire pharmaceutical lifecycle, from research and development to marketing and sales. Cadila Pharmaceuticals (Europe) Ltd is structured as a large organization with a significant workforce, emphasizing skilled personnel and a commitment to innovation. It operates under the Visa: Skilled Worker designation, with a Worker (A) rating, reflecting a high level of expertise and contribution to the company’s operations. The company’s SIC codes indicate involvement in both the sale of other particular products and wholesale of pharmaceutical goods, underscoring its multifaceted role within the pharmaceutical industry.

Cadila Pharmaceuticals (Europe) Ltd is a significant subsidiary of Cadila Pharmaceuticals Limited, a globally recognized Indian pharmaceutical enterprise. Established in 2000-11-23, the company operates as an active, long-term entity focused on the European market. Located at Amba House, Harrow, HA1 1BA, it maintains a strong international presence, strategically positioned to serve European clients. As a Ltd company, Cadila Pharmaceuticals (Europe) Ltd specializes in the development, manufacture, and distribution of a diverse portfolio of pharmaceutical products. The company’s core business centers around providing high-quality medicines and treatments across various therapeutic areas, including cardiovascular, oncology, and pain management. The company’s services encompass the entire pharmaceutical lifecycle, from research and development to marketing and sales. Cadila Pharmaceuticals (Europe) Ltd is structured as a large organization with a significant workforce, emphasizing skilled personnel and a commitment to innovation. It operates under the Visa: Skilled Worker designation, with a Worker (A) rating, reflecting a high level of expertise and contribution to the company’s operations. The company’s SIC codes indicate involvement in both the sale of other particular products and wholesale of pharmaceutical goods, underscoring its multifaceted role within the pharmaceutical industry.